ORNL image analysis prowess advances retina research

December 21, 2011

OAK RIDGE, Tenn., Dec. 21, 2011 - Armed with a new ability to find retinal anomalies at the cellular level, neurobiologists at St. Jude Children's Research Hospital have made a discovery they hope will ultimately lead to a treatment for cancer of the retina.

While much work remains, Oak Ridge National Laboratory's specialized tracing algorithm allows researchers to analyze thousands of cells instead of just a few dozen. This tool has helped reveal a previously undiscovered role of Rb, the retinoblastoma tumor suppressor gene in the developing retina. The findings are detailed in a paper published in the Proceedings of the National Academy of Sciences, available at http://www.pnas.org/content/early/2011/12/08/1108141108.abstract.

"Our paper shows that horizontal neurons known to be deficient in this gene exhibited abnormalities in the way their dendrites - the arms that connect to other cells - were organized after a certain number of days after birth," said the Department of Energy lab's Ryan Kerekes, one of the authors. The images of mouse retinas were acquired using confocal microscopy while The Jackson Laboratory provided the mice.

To make their discovery, Kerekes, ORNL colleague Shaun Gleason and postdoc Mahmut Karakaya developed a computer program and automated tool that traces the very complex and intricate dendritic arbor. This tool allows scientists to draw a line along each branch in the neuron's tree of connectors so the branch can be measured in terms of length, angle and other parameters.

"Previously, this was a very time-consuming and labor-intensive process," Kerekes said. "Existing commercial software tools were not tuned to this particular data and, as a result, produced too many tracing errors."

As a result, only a handful of cells could be analyzed in sufficient detail, according to Kerekes, who noted that the ORNL tracing algorithms achieves the level of accuracy required to analyze thousands of developing neurons.

Retinoblastoma is caused by a mutation in a gene controlling cell division, causing cells to grow out of control and become cancerous. It is most commonly found in children 2 and younger.

While this paper focused on cancer of the retina, Gleason noted that this research focuses on a number of retinal developmental issues.
-end-
The lead author of the paper, titled "Retinoblastoma (Rb) regulates laminar dendritic arbor reorganization in retinal horizontal neurons," is Michael Dyer of St. Jude Children's Research Hospital, the University of Tennessee Health Science Center at Memphis and Howard Hughes Medical Center, Chevy Chase, Md. Other authors are from the University of Tennessee at Knoxville and Memphis, Howard Hughes Medical Institute and Instituto de Biofisica Carlos Chagas Filho, Centro de Ciencias da Saude, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

This research was funded by the National Cancer Institute, the National Institutes of Health, Fogarty International Research Collaboration Award/National Institutes of Health, the American Cancer Society, the Research to Prevent Blindness Foundation and the American Lebanese Syrian Associated Charities. The image analysis work also received seed money from ORNL and St. Jude Children's Research Hospital.

UT-Battelle manages ORNL for the Department of Energy's Office of Science.

DOE/Oak Ridge National Laboratory

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.